Skip to content
Open access · OA via OpenAlex

DNA methylation in endometrial cancer

Meng Hua Tao, Jo L. Freudenheim

Epigenetics · 2010 · ▲ 89 citations

Abstract

Endometrial cancer is the most commonly diagnosed gynecological cancer, and it has been shown to be a complex disease driven by abnormal genetic, and epigenetic alterations, as well as environmental factors. Epigenetic changes resulting in aberrant gene expression are dynamic and modifiable features of many cancer types. A significant epigenetic change is aberrant DNA methylation. In this review, we review evidence on the role of aberrant DNA methylation, examining changes in relation to endometrial carcinogenesis, and report on recent advances in the understanding of the contribution of aberrant DNA methylation to endometrial cancer with the emphasis on the role of dietary/ lifestyle and environmental factors, as well as opportunities and challenges of DNA methylation in endometrial cancer management and prevention.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.4161/epi.5.6.12431
Canonical
link ↗
Fetched
2026-10-04 MST

Cite this

APA
Tao, M.H., &amp; Freudenheim, J.L. (2010). DNA methylation in endometrial cancer. <em>Epigenetics</em>. https://doi.org/10.4161/epi.5.6.12431
Vancouver
Tao MH, Freudenheim JL. DNA methylation in endometrial cancer. Epigenetics. 2010. doi:10.4161/epi.5.6.12431.
BibTeX
@article{meng2010DNAmet, title = {DNA methylation in endometrial cancer}, author = {Meng Hua Tao and Jo L. Freudenheim}, journal = {Epigenetics}, year = {2010}, doi = {10.4161/epi.5.6.12431}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings